(Q24243147)

https://api.crossref.org/works/10.1002%2F14651858.CD002312.PUB3

Intrapleural urokinase versus normal saline in the treatment of complicated parapneumonic effusions and empyema. A randomized, double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002312.PUB3

Randomised controlled trial of intrapleural streptokinase in community acquired pleural infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002312.PUB3

Intrapleural streptokinase for empyema and complicated parapneumonic effusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002312.PUB3

U.K. Controlled trial of intrapleural streptokinase for pleural infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002312.PUB3

Controlled trial of intrapleural streptokinase in the treatment of pleural empyema and complicated parapneumonic effusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002312.PUB3

Randomised trial of intrapleural urokinase in the treatment of childhood empyema

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002312.PUB3

Immediate drainage is not required for all patients with complicated parapneumonic effusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002312.PUB3

Predictors of Outcome and Long-term Survival in Patients with Pleural Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002312.PUB3

Pleural fluid chemical analysis in parapneumonic effusions. A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002312.PUB3

Intrapleurally administered streptokinase in the treatment of acute loculated nonpurulent parapneumonic effusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002312.PUB3

Abnormalities of pathways of fibrin turnover in the human pleural space

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002312.PUB3

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002312.PUB3

Thoracoscopy for empyema and hemothorax.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002312.PUB3

Empyema thoracis. Therapeutic management and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002312.PUB3

Treatment of Complicated Pleural Fluid Collections With Image-Guided Drainage and Intracavitary Urokinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002312.PUB3

Early aggressive surgical management of parapneumonic empyemas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002312.PUB3

Management of complicated parapneumonic effusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002312.PUB3

Successful treatment of empyema thoracis with human recombinant deoxyribonuclease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002312.PUB3

Intrapleural fibrinolytics in management of empyema thoracis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002312.PUB3

Intrapleural alteplase in a patient with complicated pleural effusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002312.PUB3

Intra-pleural fibrinolytic therapy vs. conservative management in the treatment of parapneumonic effusions and empyema

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002312.PUB3

Intra-pleural fibrinolytic therapy versus conservative management in the treatment of parapneumonic effusions and empyema

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002312.PUB3

Intrapleural Tissue Plasminogen Activator for Complicated Pleural Effusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002312.PUB3

The in vitro efficacy of varidase versus streptokinase or urokinase for liquefying thick purulent exudative material from loculated empyema

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002312.PUB3

7 January 2021

Use of purified streptokinase in empyema and hemothorax

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002312.PUB3

7 January 2021

Thoracoscopic debridement and pleural irrigation in the management of empyema thoracis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002312.PUB3

7 January 2021

Early use of intrapleural fibrinolytics in the management of postpneumonic empyema. A prospective study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002312.PUB3

7 January 2021

Management of parapneumonic effusions

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002312.PUB3

7 January 2021

Instillation of Fibrinolytic Enzymes in the Treatment of Pleural Empyema

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002312.PUB3

7 January 2021

Thoracic empyema: management with image-guided catheter drainage

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002312.PUB3

7 January 2021

Intrapleural streptokinase in experimental empyema

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002312.PUB3

7 January 2021

The systemic fibrinolytic activity of intrapleural streptokinase

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002312.PUB3

7 January 2021

Empirical treatment with fibrinolysis and early surgery reduces the duration of hospitalization in pleural sepsis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002312.PUB3

7 January 2021

A New Classification of Parapneumonic Effusions and Empyema

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002312.PUB3

7 January 2021

Intrapleural fibrinolysis with streptokinase as an adjunctive treatment in hemothorax and empyema: a multicenter trial.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002312.PUB3

7 January 2021

A randomized trial of empyema therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002312.PUB3

7 January 2021

Effect of intrapleural streptokinase administration on antistreptokinase antibody level in patients with loculated pleural effusions

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002312.PUB3

7 January 2021

Effect of repeated thoracenteses on fluid characteristics, cytokines, and fibrinolytic activity in malignant pleural effusion

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002312.PUB3

7 January 2021

Intrapleural fibrinolytic agents for empyema and complicated parapneumonic effusions: a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002312.PUB3

7 January 2021

Tissue plasminogen activator combined with human recombinant deoxyribonuclease is effective therapy for empyema in a rabbit model

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002312.PUB3

7 January 2021

Major hemorrhage following administration of intrapleural streptokinase

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002312.PUB3

7 January 2021

Streptokinase in a loculated pleural effusion. Effectiveness determined by site of instillation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002312.PUB3

7 January 2021

10.1002/14651858.CD002312.PUB3

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

18425881

1 reference

Consolidated OpenCitations Corpus – April 2017